Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2014, Vol. 8 Issue (3) : 316-320    https://doi.org/10.1007/s11684-014-0354-y
REVIEW
Discussion of solutions to ethical issues in real-world study
Sicheng Wang1,Baoyan Liu2,*(),Ningning Xiong3,Qi Xie4,Runshun Zhang5,Xuezhong Zhou6,Jie Qiao7
1. Department of Science and Technology, State Administration of Traditional Chinese Medicine of the People’s Republic of China, Beijing 100027, China
2. China Academy of Chinese Medical Sciences, Beijing 100700, China
3. GCP Center, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing 210029, China
4. Institute of Basic Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China
5. Department of Gastroenterology, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
6. School of Computer and Information Technology, Beijing Jiaotong University, Beijing 100044, China
7. Office of Ethic Committee, Guang’anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
 Download: PDF(87 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

In recent years, the paradigm of real-world study (RWS) has been at the forefront of clinical research worldwide, particularly in the field of traditional Chinese medicine. In this paper, basic features and nature of real-world clinical studies are discussed, and ethical issues in different stages of RWS are raised and reviewed. Moreover, some preliminary solutions to these issues, such as protecting subjects during the process of RWS and performing ethical review, are presented based on recent practices and basic ethical rules to improve the scientific validity and ethical level of RWS.

Keywords real-world study      ethics      strategy     
Corresponding Author(s): Baoyan Liu   
Online First Date: 02 September 2014    Issue Date: 09 October 2014
 Cite this article:   
Sicheng Wang,Baoyan Liu,Ningning Xiong, et al. Discussion of solutions to ethical issues in real-world study[J]. Front. Med., 2014, 8(3): 316-320.
 URL:  
https://academic.hep.com.cn/fmd/EN/10.1007/s11684-014-0354-y
https://academic.hep.com.cn/fmd/EN/Y2014/V8/I3/316
1 Ren DQ. Real-world study, GCP and risk minimization. Chin J Chin Mater Med (Zhongguo Zhong Yao Za Zhi)2012; 37(18): 2681-2682 (in Chinese)
2 Tian F, Xie YM. Real-world study: a potential new approach to effectiveness evaluation of traditional Chinese medicine interventions. J Chin Integr Med (Zhong Xi Yi Jie He Xue Bao)2010; 8(4): 301-306 (in Chinese)
https://doi.org/10.3736/jcim20100401 pmid: 20388468
3 Liu BY, Zhou XZ, Li P, Wang YH, Wen TC, Guo YF, Zhang RS, Chen SB. A unified clinical and research information platform toward individual medicine. China Digit Med (Zhongguo Shu Zi Yi Xue)2007; 2(6): 31-36 (in Chinese)
4 Gallin JI.,. Ognibene FP. Principle and Practice of Clinical Research (2nd ed) (in Chinese, trans. Zhang YF). Beijing: Science Press, 2008: 17-27
5 National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. The Belmont Report. Washington, DC, U.S. Government Printing Office. 1979
6 Liu BY, Zhang QM. Symptoms’ standardization issues in the construction of unified TCM clinical and research information platform. J Tradit Chin Med (Zhong Yi Za Zhi)2011; 52(20): 1714-1718 (in Chinese)
7 Wang SC, Wang XQ, Xiong NN. Promote the implementation of ethical regulation and build subjects protection system. Chin J Manag Chin Med (Zhong Yi Yao Guan Li Za Zhi), 2011, (12): 895-898 (in Chinese)
8 Code of Federal Regulations. Protection of human subjects. Title 45 Part 46, June 23. 2005: §46.101
9 Tian DX. Ethical Controversy of Minimal Risk in Clinical Research. Med Philos Humanist Soc Med Ed (Yi Xue Yu Zhe Xue, Ren Wen She Hui Yi Xue Ban)2011; 32(7): 13-15 (in Chinese)
10 Zhou YJ, Hong M. Ethical requirements of the hospital digital technology construction. Chin Med Ethics (Zhongguo Yi Xue Lun Li Xue)2010; 23(3): 109-111 (in Chinese)
11 Song HM, Liu BY, He LY, Zhang RS, Zhou XZ. Needs of data mining and pre-processing method of data in TCM clinical and research information integration system. Chin J Basic Med Tradit Chin Med (Zhongguo Zhong Yi Ji Chu Yi Xue Za Zhi)2011; 17(12): 1323-1325 (in Chinese)
12 World Medical Association. Declaration of Helsinki. <month>October</month>2013.
13 Council for International Organizational of Medical Sciences. International Ethical Guidelines for Biomedical Research Involving Human Subjects. Geneva, 2002.
14 Hu JH, Huang J. Current status and prospect of the medical research ethics. Chin Bull Life Sci (Sheng Ming Ke Xue)2012; 11(24): 1254-1255 (in Chinese)
15 Wang SC, Wang XQ, Xiong NN, Yu H. Countermeasure to ethical review development of TCM clinical research. J Beijing Univ Tradit Chin Med (Beijing Zhong Yi Yao Da Xue Xue Bao)2010; 33(3): 156-158 (in Chinese)
16 Chen Z.Unity but not Uniformity: Globality and Locality of Bioethics. Chin Med Ethics (Zhongguo Yi Xue Lun Li Xue), 2006, 19(4): 3-4, 10 (in Chinese)
[1] Yufeng Zhao, Xueyun Yu, Xinyu Cao, Lin Luo, Liyun He, Shusong Mao, Li Ma, Peijing Rong, Yuxue Zhao, Guozheng Li, Baoyan Liu. Cluster analysis for syndromes of real-world coronary heart disease with angina pectoris[J]. Front. Med., 2018, 12(5): 566-571.
[2] Douglas Sipp. The unregulated commercialization of stem cell treatments: a global perspective[J]. Front Med, 2011, 5(4): 348-355.
[3] Zhenji Li, Chunbo Xu. The fundamental theory of traditional Chinese medicine and the consideration in its research strategy[J]. Front Med, 2011, 5(2): 208-211.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed